CASUS vs. APACHE II in Predicting Mortality After Coronary Artery Bypass Grafting
NCT ID: NCT05026437
Last Updated: 2021-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
204 participants
OBSERVATIONAL
2019-01-02
2019-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Perioperative Results on Mortality in Coronary Artery Bypass Surgery
NCT06812624
Predictors of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Prospective Cohort Study
NCT04193813
Postoperative Stroke and Epiaortic Ultrasound in CABG
NCT07101393
Myocardial Injury Noncardiac Surgery in Geriatric Patients
NCT06957106
Prevalence of Frailty and Associated Factors in Coronary Artery Bypass Patients
NCT06343168
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac surgery score and APACHE II scoring
Cardiac surgery score and APACHE II will calculated on the first postoperative day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 years of age
* Staying at least 24 hours in the cardiac intensive care unit
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
OTHER
Haydarpasa Numune Training and Research Hospital
OTHER
Antalya Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nihan YAPICI
Role: STUDY_DIRECTOR
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery TRH
Sümeyye UĞUR
Role: PRINCIPAL_INVESTIGATOR
Haydarpaşa Numune Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital in Turkey
Istanbul, , Turkey (Türkiye)
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SU2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.